Successful treatment of advanced idiopathic myelofibrosis with imatinib mesylate

Eur J Haematol. 2004 Aug;73(2):147-8. doi: 10.1111/j.1600-0609.2004.00264.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Benzamides
  • Cytogenetic Analysis
  • Humans
  • Imatinib Mesylate
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Primary Myelofibrosis / drug therapy*
  • Primary Myelofibrosis / etiology
  • Pyrimidines / therapeutic use*
  • Treatment Outcome

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate